Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of GR2001 in Chinese Healthy Adults

NCT06302374 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

202

Enrollment

INDUSTRY

Sponsor class

Conditions

Tetanus

Interventions

BIOLOGICAL: GR2001
BIOLOGICAL: Placebo
BIOLOGICAL: HTIG
BIOLOGICAL: Tetanus Toxoid

Sponsor

Genrix (Shanghai) Biopharmaceutical Co., Ltd.